Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
ICON Public Limited Company ICLR
$199.74
+$0.63 (0.32%)
На 18:00, 12 мая 2023
+20.78%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
16072713512.00000000
-
week52high
249.62
-
week52low
171.43
-
Revenue
7741386000
-
P/E TTM
30
-
Beta
1.11937700
-
EPS
5.87000000
-
Last Dividend
0.00000000
-
Next Earnings Date
27 апр 2023 г. в 12:00
Описание компании
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
Credit Suisse | Neutral | 25 авг 2022 г. | |
Deutsche Bank | Buy | Buy | 14 июл 2022 г. |
Barclays | Equal-Weight | Equal-Weight | 13 июл 2022 г. |
Citigroup | Buy | Buy | 08 июл 2022 г. |
Guggenheim | Buy | 24 мая 2022 г. | |
Barclays | Equal-Weight | Equal-Weight | 12 сент 2022 г. |
UBS | Buy | 07 сент 2022 г. | |
Barclays | Equal-Weight | Equal-Weight | 06 окт 2022 г. |
Guggenheim | Buy | Buy | 10 окт 2022 г. |
Mizuho | Buy | Buy | 10 ноя 2022 г. |
B of A Securities | Buy | Neutral | 09 ноя 2022 г. |
Guggenheim | Buy | Buy | 20 янв 2023 г. |
Barclays | Overweight | Equal-Weight | 17 янв 2023 г. |
Barclays | Overweight | Equal-Weight | 13 янв 2023 г. |
Baird | Outperform | Outperform | 12 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
ICON Public Limited Company (ICLR) Q1 2023 Earnings Call Transcript
Seeking Alpha
27 апр 2023 г. в 14:22
ICON Public Limited Company (ICLR) Q1 2023 Earnings Call Transcript.
Icon PLC (ICLR) Q1 Earnings and Revenues Lag Estimates
Zacks Investment Research
26 апр 2023 г. в 20:30
Icon PLC (ICLR) came out with quarterly earnings of $2.90 per share, missing the Zacks Consensus Estimate of $2.98 per share. This compares to earnings of $2.76 per share a year ago.
2 Clinical Research Stocks That Could Grow by More Than 10% This Year, and 1 to Watch
The Motley Fool
25 мар 2023 г. в 07:20
Icon's double digit earnings growth forecast should drive its stock price. IQVIA's increased operational efficiency and earnings growth should drive its share price.
Should You Bring The Luck Of The Irish To Your Investmets?
MarketBeat
17 мар 2023 г. в 06:56
For St. Patrick's Day, you might crack open a Guinness brewed by Diageo PLC (NYSE: DEO). If that inspires you to investigate how Irish stocks may fit into your portfolio, you have quite a few to choose from.
ICON Public Limited Company (ICLR) Q4 2022 Earnings Call Transcript
Seeking Alpha
23 февр 2023 г. в 12:19
ICON Public Limited Company (NASDAQ:ICLR ) Q4 2022 Earnings Conference Call February 23, 2023 8:00 AM ET Company Participants Kate Haven - VP of IR Brendan Brennan - CFO Steve Cutler - CEO Conference Call Participants Sandy Draper - Guggenheim Justin Bowers - Deutsche Bank Patrick Donnelly - Citi Eric Coldwell - Baird Casey Woodring - JPMorgan David Windley - Jefferies Elizabeth Anderson - Evercore Dan Leonard - Credit Suisse Jack Meehan - Nephron Research Derik De Bruin - Bank of America Operator Good day and thank you for standing by. Welcome to the ICON Q4 and Full Year 2022 Earnings Conference Call.